A variety of novel and effective inhibitors of NQO1 was synthesized. The inhibitors were classified as 'asymmetrical' and 'halfway stage' analogues of dicoumarol. The synthesis of these inhibitors was achieved through the application of different techniques such as 'borrowing hydrogen methodology', thermal and microwave irradiation and reductive C-C cleavage using NaBH3CN. One of the most potent analogues was toxic (IC50 = 9.2 ± 0.3 μM) towards the non-small cell lung cancer cell line, A549.A selection of the most potent inhibitors was re-modified as prodrugs in order to improve drug penetration through the barrier of the cell membrane. This was achieved by conjugation with a delivery agent related to the natural product antheminone A. The synthesis involved a multi-step reaction sequence involving the use of natural product (-)-quinic acid as a precursor. A range of prodrugs were synthesized which exhibited toxicity towards the A549 cancer cell line.
Date of Award | 1 Aug 2016 |
---|
Original language | English |
---|
Awarding Institution | - The University of Manchester
|
---|
Supervisor | Roger Whitehead (Supervisor) |
---|
- Synthesis, Inhibitors, Enzyme and MTT assays
Synthesis of Analogues of Dicoumaroland their Measurementas Inhibitors of NQO1
Obi, J. (Author). 1 Aug 2016
Student thesis: Phd